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INTRODUCTION
 Multifetal pregnancies are associated with an increased 
risk of perinatal mortality compared to unifetal pregnancies. 
The incidence of single fetal death in twin pregnancy varies 
from 0.5% - 6.8%. The importance of chorionicity is evident 
in the prevalence of monochorionicity in death of one of the 
twins, which is around 50% - 70%. This event has potential 
consequences for the surviving fetus (co-twin), including in-
creased risk of fetal death, neurological morbidity, preterm 
delivery (PTD) and associated sequelae.1-3
 The etiology of death of a twin often can’t be determined 
but there’re several conditions that may be associated, 
particularly twin-to-twin transfusion syndrome (TTTS), 
velamentous insertion of the umbilical cord, true umbilical 
cord knot, birth defects and fetal growth restriction (FGR).1-3
 Chorionicity determines the prognosis of co-twin 
survivor, being worse in monochorionic pregnancies. The 
placental vascular anastomoses present in this kind of 
twin pregnancy are responsible for early hemodynamic 
changes after the death of one of the twins, and therefore 
not preventable by termination of pregnancy, with sudden 
drop in blood pressure, exsanguination, severe anemia and 
ischemic lesions in the white matter/brain cyst formation in 
the co-twin survivor.1-3
 The timing of death (gestational age in which it occurs) 
is crucial in the future implications of twin pregnancy.1-3
 
CASE REPORT
 The authors describe a case of a 32-year-old pregnant 
woman, smoking 20 cigarettes/day until the beginning 
of pregnancy and without other relevant medical history. 
III gesta I para (eutocic delivery 13 years ago, with 
newborn female, 3450 g, healthy) I miscarriage. The first 
trimester’s obstetric ultrasound diagnosed monochorionic/
diamniotic twin pregnancy; fetal abnormalities or 
ultrasonographic installation signs of TTTS weren’t 
detected. The ultrasonographic screening for aneuploidies 
was negative. The pregnant woman began maternal and 
fetal surveillance in obstetrics high risk consultation having 
made selective scans each two weeks from 16 weeks 
on (TTTS screening). During this evaluation the TTTS 
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The incidence of single fetal death in twin pregnancy varies from 0.5% - 6.8%, leaving the surviving fetus with increased morbi-mortality. 
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termination of pregnancy at 33 weeks after documentation of brain changes in the surviving fetus.
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RESUMO
A incidência de morte fetal de um feto na gestação gemelar varia de 0,5% - 6,8%, deixando o feto sobrevivente com morbi-mortalidade 
aumentada. O prognóstico é pior em gestações monocoriónicas. Ao abordar estes casos importa realçar a referenciação a centro 
terciário com apoio perinatal diferenciado, a indução da maturação pulmonar fetal e a interrupção da gravidez se houver perda de bem-
-estar fetal ou possibilidade de complicações maternas ou suspeita de sequelas neurológicas no feto sobrevivente, devendo os riscos 
da prematuridade iatrogénica serem sempre pesados com as possíveis sequelas decorrentes da permanência do feto num ambiente 
uterino hostil. Os autores descrevem o caso de uma mulher de 32 anos com gravidez monocoriónica/diamniótica com morte de um dos 
fetos, com restrição de crescimento grave e inserção velamentosa do cordão umbilical, pelas 30 semanas de gestação. O casal optou 
pela terminação da gravidez às 33 semanas, após documentação de alterações cerebrais no feto sobrevivente.
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Figure 1 - Obstetric Ultrasound – 32 weeks of gestation – abnormal 
justaventricular image with apparent cerebral ventricular dilation
Figure 2 - Fetal cerebral MRI – 32 weeks of gestation – signal focal changes in the periventricular white matter, which may correspond to 
hypoxic-ischemic lesions with evolution greater than one week
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was always excluded. At 22 weeks it was documented 
normal fetal echocardiograms. At 25 weeks, fetus two was 
diagnosed with FGR; the pregnant woman initiated weekly 
fetal monitoring with ultrasound (including umbilical artery 
(UA) and middle cerebral artery (MCA) fluxometries) and 
cardiotocography (biophysical profile), whose results 
were never altered; fetus two maintained severe FGR in 
the biometric revaluation each two weeks. At 30 weeks, 
death of fetus two was diagnosed (affected with severe 
FGR); fetus one had growth and UA and MCA fluxometries 
were kept within the normal range. Surveillance began 
with weekly fetal ultrasound evaluation (including cerebral 
ecoanatomy) and biweekly cardiotocography. Maturation of 
the fetal lung maturity with betamethasone was performed. 
One abnormal justaventricular image was diagnosed with 
apparent cerebral ventricular dilation in the surviving fetus 
at 32 weeks (Fig. 1), which led to the realization of fetal 
brain magnetic resonance imaging (MRI) which revealed 
focal changes in the periventricular white matter, particularly 
in peri-trigonal regions bilaterally, that may correspond to 
hypoxic-ischemic lesions with evolution greater than one 
week, and left ventricle with about 10.5 mm of greater 
diameter (Fig. 2). Given the brain changes in the surviving 
fetus, the couple decided to terminate the pregnancy. An 
elective caesarean section was performed for termination 
of pregnancy (33 weeks), with male newborn with 1850 g 
hospitalized in Neonatology for surveillance by prematurity.
 The histological examination revealed monochorionic/
diamniotic placenta weighing less than expected, with 
velamentous insertion of the umbilical cord, calcifications 
and hyalinized villi in placental area in relation to fetus two.
 The evolution of the newborn in Neonatology was 
favorable with neurological examination without changes. 
The transfontanellar ultrasound (TU) on the second day of 
life revealed focal lesions likely to represent ischemic insult 
(Fig. 3A). Repeated TU on the fifteenth day of life (discharge 
day) showed bilateral paratrigonal hyperechogenicity 
outbreaks. At two months of life the newborn had good 
weight progression, neurological examination without 
changes, adequate psycho-motor development and TU with 
fine and imprecise brain changes (Fig. 3B).
 After four years of follow up, the child shows spastic 
hemiparesis of the lower left- member with hypertonia and 
hyperreflexia, but his growth and development are age 
appropriate. The latest brain MRI scan was normal.
DISCUSSION
 The approach and the timing of the termination of 
pregnancy in cases of death of one twin in early gestational 
ages where the fetal viability is not yet established are 
not consensual, being necessary to weigh the risk of 
iatrogenic prematurity with the risk of staying in a hostile 
uterine environment. Present recommendations are limited 
because of the absence of randomized controlled trials. 
Some authors advocate a conservative approach until 
37 weeks of pregnancy, if documented fetal well-being, 
because an early obstetric intervention may be associated 
with iatrogenic prematurity and increased neurological 
morbidity of the surviving fetus, compared with the expected 
effects of death of one of the twins in the co-twin survivor.1-3
 Determining the mode of delivery should be considered 
by obstetric criteria and by prematurity with the possibility 
of vaginal delivery. The approach should always be 
individualized, with support and advice tailored to parents. 
In addressing these cases it should be noted referral to 
tertiary center with differentiated perinatal support, induction 
of fetal lung maturation and termination of pregnancy if 
there is loss of fetal well-being or risk of serious maternal 
complications and suspected neurological sequelae in the 
surviving fetus.1-3
 As a prognostic predictor of cerebral palsy, the 
abnormalities detected by cerebral MRI near full term 
allow to predict neurodevelopmental disorders of the child. 








However, it is important to point out that a substantial 
proportion of children with moderate to severe changes in 
white matter have normal neurodevelopment, although a 
longer follow up is needed.3-6
 In the case presented, the death of one of the 
monochorionic twins was due to severe FGR, with probable 
origin in velamentous insertion of the umbilical cord. Imaging 
changes that could translate to possible neurological 
sequelae of the surviving fetus led the couple to choose 
the termination of pregnancy at 33 weeks by caesarean 
section, but medical advice was conducted in order to warn 
that the identified neurological disorders originated in the 
death of co-twin (already installed and to expressing the 
expected natural history) and the termination of pregnancy 
in this time could bring more complications associated with 
prematurity.1-3
 TTTS is a potential complication of 5% - 15% of 
monochorionic pregnancies that if left untreated can be 
associated with 90% of perinatal mortality.7 In the surveillance 
of a monochorionic pregnancy this complication should 
always be actively searched. In the present case report 
TTTS was never detected. The ultrasonographic signs of 
TTTS installation are in the first trimester of pregnancy 
the disagreement of the skull-rump length or nuchal 
translucency (> 20%) of fetuses, the existence of a nuchal 
translucency upper the 95th percentile in one of the fetuses 
or presence of an inverted a wave in the ductus venosus 
of at least one of the fetuses8; in the second trimester the 
presence of TTTS is defined as the appearance of oligo/
hydramnios sequence.7
 The pediatric follow up carried out showed minor 
changes in the psycho-motor development of the child born.
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Figure 3 - Newborn transfontanelar ultrasound: (A) second day of life – focal hyperechoic periventricular lesions, predominantly on the 
left, which are associated with extensive hyperechogenicity in the periventricular white matter, in relation with probable ischemic etiology.
(B) Two months of age (real age) – few small hyperechoic foci of imprecise nature.
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INTRODUÇÃO
 O lítio tem como principal indicação a doença bipolar. 
É um fármaco de excreção renal, de forma semelhante ao 
sódio, e é dialisável.1,2 Tem uma janela terapêutica estrei-
ta, exigindo ajuste progressivo das doses, de acordo com 
os níveis séricos, a resposta clínica e o aparecimento de 
efeitos laterais. Concomitantemente, exige uma monitori-
zação regular da função renal, tiroidéia e cardiovascular, 
e ainda do equilíbrio hidroelectrolítico (a cada seis meses 
no mínimo).2 Deve ser utilizado com precaução quando 
associado a fármacos que alterem a excreção de sódio 
[anti-inflamatórios não esteróides (AINEs), diuréticos tiazí-
dicos, inibidores da enzima de conversão da angiotensina 
(iECAs) ou antagonistas dos receptores da angiotensina II 
(ARAs)],2 bem como ao associá-lo a fármacos neurolépti-
cos. A sua toxicidade relaciona-se com os níveis séricos; 
no entanto, pode ocorrer mesmo sob níveis terapêuticos,1,2 
sendo potenciada pela desidratação ou pela deterioração 
da função renal. As principais manifestações clínicas são 
as gastrointestinais (náuseas, vómitos, diarreia) e as neu-
rológicas (lentificação, fala arrastada, ataxia, confusão, agi-
tação, irritabilidade neuromuscular, tremor, fasciculações, 
mioclonias; em casos graves, convulsões, estado de mal 
não convulsivo, encefalopatia). O tratamento passa por hi-
dratação endovenosa e hemodiálise.1,2 
CASO CLÍNICO
 Apresentamos o caso de um homem de 66 anos de 
idade, com história de hipertensão arterial (sob bisoprolol 
e associação de irbesartan com hidroclorotiazida), diabe-
tes mellitus tipo 2 (sob metformina e gliclazida), doença 
renal crónica estádio 3, hipotiroidismo e doença bipolar 
sob terapêutica com lítio 400 mg duas vezes por dia há 
mais de 20 anos, fluvoxamina e lorazepam, sem seguimen-
to ou controlo analítico há cerca de três anos. Foi levado 
ao Serviço de Urgência (SU) pela esposa, por agitação e 
descoordenação motora. A esposa descrevia quadro com 
cerca de três meses de evolução, constituído por disp-
neia de esforço com agravamento progressivo, ortopneia 
e edema dos membros inferiores, associado a irritabilida-
de, ansiedade, agitação, inquietude, insónia, anorexia e 
diarreia intermitente. Tinha sido observado recentemente 
pela Psiquiatria no SU, tendo tido alta com alterações da 
terapêutica psicotrópica. Foi posteriormente reavaliado 
pela Psiquiatra assistente, que introduziu terapêutica diu-
rética e referenciou o doente ao Médico Assistente para 
doseamento de lítio. À admissão no SU, apresentava-se 
desorientado no tempo, agitado, confuso e lentificado, com 
ataxia e tremor generalizado, bem como fasciculações dos 
membros superiores. Sem défices neurológicos focais. Pa-
râmetros vitais estáveis, dentro dos limites da normalidade. 
RESUMO
O lítio é um fármaco com janela terapêutica estreita, exigindo monitorização frequente dos seus níveis séricos e da clínica, pois a 
toxicidade pode surgir mesmo com níveis terapêuticos. Apresentamos o caso de um homem com intoxicação por lítio, com persistência 
de alterações neurológicas mesmo após normalização dos seus níveis séricos, permitindo-nos fazer o diagnóstico de síndrome de 
neurotoxicidade irreversível causada pelo lítio (SILENT).
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ABSTRACT
Lithium has a narrow therapeutic window. Frequent monitoring of both serum levels and clinical signs of toxicity is warranted because 
toxicity may be present even when concentrations are within the therapeutic range. We report the case of a man with lithium poisoning, 
with persistent neurologic signs and symptoms even after removal of lithium from circulation – a diagnosis of syndrome of irreversible 
lithium-effectuated neurotoxicity (SILENT) was made.
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